Anorectic drugs and vascular disease: The role of voltage-gated K⁺ channelsMICHELAKIS, Evangelos.Vascular pharmacology. 2002, Vol 38, Num 1, pp 51-59, issn 1537-1891Article

The role of the NO axis and its therapeutic implications in Pulmonary Arterial HypertensionMICHELAKIS, Evangelos D.Heart failure reviews. 2003, Vol 8, Num 1, pp 5-21, issn 1382-4147, 17 p.Article

The role of mitochondria in pulmonary vascular remodeling : The role of mitochondrial fission, fussion and biogenesis in cardiovascular diseasesDROMPARIS, Peter; SUTENDRA, Gopinath; MICHELAKIS, Evangelos D et al.Journal of molecular medicine (Berlin. Print). 2010, Vol 88, Num 10, pp 1003-1010, issn 0946-2716, 8 p.Article

Phosphodiesterase Type 5 Inhibitors for Pulmonary Arterial HypertensionARCHER, Stephen L; MICHELAKIS, Evangelos D.The New England journal of medicine. 2009, Vol 361, Num 19, pp 1864-1871, issn 0028-4793, 8 p.Article

Emerging Concepts and Translational Priorities in Pulmonary Arterial HypertensionMICHELAKIS, Evangelos D; WILKINS, Martin R; RABINOVITCH, Marlene et al.Circulation (New York, N.Y.). 2008, Vol 118, Num 14, pp 1486-1495, issn 0009-7322, 10 p.Article

Anorectic drugs and pulmonary hypertension from the bedside to the benchMICHELAKIS, Evangelos D; WEIR, E. Kenneth.The American journal of the medical sciences. 2001, Vol 321, Num 4, pp 292-299, issn 0002-9629Article

Metabolic modulation as a novel cancer treatmentDROMPARIS, Peter; SUTENDRA, Gopinath; MICHELAKIS, Evangelos D et al.Heart and metabolism. 2011, Num 51, pp 20-26, issn 1566-0338, 7 p.Article

Point :Counterpoint : Release of an endothelium-derived vasoconstrictor and RhoA/Rho kinase-mediated calcium sensitization of smooth muscle cell contraction are/are not the main effectors for full and sustained hypoxic pulmonary vasoconstrictionROBERTSON, Tom P; ROCHEFORT, Gaël Y; MICHELAKIS, Evangelos D et al.Journal of applied physiology (1985). 2007, Vol 102, Num 5, pp 2071-2080, issn 8750-7587, 10 p.Article

A Global Pulmonary Arterial Hypertension Registry: Is It Needed? Is It Feasible?: Pulmomary Vascular Disease: The Global PerspectiveGOMBERG-MAITLAND, Mardi; MICHELAKIS, Evangelos D.Chest (American College of Chest Physicians). 2010, Vol 137, Num 6, issn 0012-3692, 95S-101S, SUPPArticle

Comprehensive Invasive and Noninvasive Approach to the Right Ventricle-Pulmonary Circulation Unit: State of the Art and Clinical and Research ImplicationsCHAMPION, Hunter C; MICHELAKIS, Evangelos D; HASSOUN, Paul M et al.Circulation (New York, N.Y.). 2009, Vol 120, Num 11, pp 992-1007, issn 0009-7322, 16 p.Article

Use of Sildenafil for safe improvement of Erectile Function and quality of life in men With New York Heart Association classes II and III congestive Heart Failure a prospective, placebo-controlled, double-blind crossover trialWEBSTER, Linda J; MICHELAKIS, Evangelos D; DAVIS, Terry et al.Archives of internal medicine (1960). 2004, Vol 164, Num 5, pp 514-520, issn 0003-9926, 7 p.Article

Sildenafil reverses O₂ constriction of the rabbit ductus arteriosus by inhibiting type 5 phosphodiesterase and activating BK_Ca channelsTHEBAUD, Bernard; MICHELAKIS, Evangelos; WU, Xi-Chen et al.Pediatric research. 2002, Vol 52, Num 1, pp 19-24, issn 0031-3998Article

Attenuating Endoplasmic Reticulum Stress as a Novel Therapeutic Strategy in Pulmonary HypertensionDROMPARIS, Peter; PAULIN, Roxane; STENSON, Trevor H et al.Circulation (New York, N.Y.). 2013, Vol 127, Num 1, pp 115-125, issn 0009-7322, 11 p.Article

The pathobiology of pulmonary hypertension : Smooth muscle cells and ion channelsMICHELAKIS, Evangelos D; WEIR, E. Kenneth.Clinics in chest medicine. 2001, Vol 22, Num 3, issn 0272-5231, viii, 419-432 [15 p.]Article

Aetiology and management of male erectile dysfunction and female sexual dysfunction in patients with cardiovascular diseaseARCHER, Stephen L; GRAGASIN, Ferrante S; WEBSTER, Linda et al.Drugs & aging. 2005, Vol 22, Num 10, pp 823-844, issn 1170-229X, 22 p.Article

Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: Comparison with inhaled nitric oxideMICHELAKIS, Evangelos; TYMCHAK, Wayne; LIEN, Dale et al.Circulation (New York, N.Y.). 2002, Vol 105, Num 20, pp 2398-2403, issn 0009-7322Article

Relevant Issues in the Pathology and Pathobiology of Pulmonary HypertensionTUDER, Rubin M; ARCHER, Stephen L; DORFMÜLLER, Peter et al.Journal of the American College of Cardiology. 2013, Vol 62, Num 25, issn 0735-1097, D4-D12, SUPDConference Paper

Critical Role of the Axonal Guidance Cue EphrinB2 in Lung Growth, Angiogenesis, and RepairVADIVEL, Arul; VAN HAAFTEN, Tim; ALPHONSE, Rajesh S et al.American journal of respiratory and critical care medicine. 2012, Vol 185, Num 5, pp 564-574, issn 1073-449X, 11 p.Article

An Official American Thoracic Society Statement: Pulmonary Hypertension PhenotypesDWEIK, Raed A; ROUNDS, Sharon; MICHELAKIS, Evangelos et al.American journal of respiratory and critical care medicine. 2014, Vol 189, Num 3, pp 345-355, issn 1073-449X, 11 p.Article

Right ventricular diastolic dysfunction and the acute effects of sildenafil in pulmonary hypertension patients. CommentaryNAGENDRAN, Jayan; MICHELAKIS, Evangelos; POSTMUS, Pieter E et al.Chest. 2007, Vol 132, Num 1, issn 0012-3692, 2-5, 11-17 [11 p.]Article

Innovative strategic canadian research training from tomorrOw's Research Cardiovascular Health care Professionals (TORCH)ARMSTRONG, Paul W; EZEKOWITZ, Christina; MICHELAKIS, Evangelos et al.Clinical and investigative medicine. 2004, Vol 27, Num 1, pp 33-41, issn 0147-958X, 9 p.Article

Riociguat for Patients With Pulmonary Hypertension Caused by Systolic Left Ventricular Dysfunction: A Phase IIb Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Hemodynamic StudyBONDERMAN, Diana; GHIO, Stefano; SEMIGRAN, Marc J et al.Circulation (New York, N.Y.). 2013, Vol 128, Num 5, pp 502-511, issn 0009-7322, 10 p.Article

Assessment of mortality after long-term follow-up of patients with community-acquired Pneumonia. CommentaryMORTENSEN, Eric M; KAPOOR, Wishwa N; CHANG, Chung-Chou H et al.Clinical infectious diseases. 2003, Vol 37, Num 12, pp 1617-1628, issn 1058-4838, 12 p.Article

Statin therapy, alone or with rapamycin, does not reverse monocrotaline pulmonary arterial hypertension : the rapamcyin-atorvastatin-simvastatin studyMCMURTRY, M. Sean; BONNET, Sebastien; MICHELAKIS, Evangelos D et al.American journal of physiology. Lung cellular and molecular physiology. 2007, Vol 37, Num 4, issn 1040-0605, L933-L940Article

Diversity in mitochondrial function explains differences in vascular oxygen sensingMICHELAKIS, Evangelos D; HAMPL, Vaclav; NSAIR, Ali et al.Circulation research. 2002, Vol 90, Num 12, pp 1307-1315, issn 0009-7330Article